MetLife Investment Management’s Dorman Products DORM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.15M | Buy |
15,757
+381
| +2% | +$45.1K | 0.01% | 1108 |
|
|
2026
Q1 | $1.6M | Buy |
15,376
+137
| +0.9% | +$16.3K | 0.01% | 1176 |
|
|
2025
Q4 | $1.88M | Sell |
15,239
-884
| -5% | -$119K | 0.01% | 1104 |
|
|
2025
Q3 | $2.51M | Sell |
16,123
-338
| -2% | -$48.5K | 0.01% | 985 |
|
|
2025
Q2 | $2.02M | Buy |
16,461
+1,352
| +9% | +$164K | 0.01% | 983 |
|
|
2025
Q1 | $1.82M | Sell |
15,109
-223
| -1% | -$28.4K | 0.01% | 1082 |
|
|
2024
Q4 | $1.99M | Buy |
15,332
+259
| +2% | +$33.2K | 0.01% | 1045 |
|
|
2024
Q3 | $1.71M | Sell |
15,073
-228
| -1% | -$24K | 0.01% | 1105 |
|
|
2024
Q2 | $1.4M | Buy |
15,301
+1,714
| +13% | +$157K | 0.01% | 1163 |
|
|
2024
Q1 | $1.31M | Sell |
13,587
-486
| -3% | -$41.9K | 0.01% | 1149 |
|
|
2023
Q4 | $1.17M | Hold |
14,073
| – | – | 0.01% | 1217 |
|
|
2023
Q3 | $1.07M | Hold |
14,073
| – | – | 0.01% | 1193 |
|
|
2023
Q2 | $1.11M | Buy |
14,073
+219
| +2% | +$18.4K | 0.01% | 1212 |
|
|
2023
Q1 | $1.2M | Hold |
13,854
| – | – | 0.01% | 1138 |
|
|
2022
Q4 | $1.12M | Hold |
13,854
| – | – | 0.01% | 1166 |
|
|
2022
Q3 | $1.14M | Hold |
13,854
| – | – | 0.01% | 1120 |
|
|
2022
Q2 | $1.52M | Hold |
13,854
| – | – | 0.01% | 1009 |
|
|
2022
Q1 | $1.32M | Buy |
13,854
+4,839
| +54% | +$469K | 0.01% | 1179 |
|
|
2021
Q4 | $1.02M | Sell |
9,015
-723
| -7% | -$78.5K | 0.01% | 1115 |
|
|
2021
Q3 | $922K | Hold |
9,738
| – | – | 0.01% | 1157 |
|
|
2021
Q2 | $1.01M | Hold |
9,738
| – | – | 0.01% | 1156 |
|
|
2021
Q1 | $1,000K | Sell |
9,738
-1,112
| -10% | -$111K | 0.01% | 1158 |
|
|
2020
Q4 | $942K | Hold |
10,850
| – | – | 0.01% | 1166 |
|
|
2020
Q3 | $981K | Sell |
10,850
-1,026
| -9% | -$82K | 0.01% | 1038 |
|
|
2020
Q2 | $797K | Buy |
11,876
+739
| +7% | +$47.5K | 0.01% | 1121 |
|
|
2020
Q1 | $616K | Sell |
11,137
-921
| -8% | -$62.7K | 0.01% | 1107 |
|
|
2019
Q4 | $913K | Hold |
12,058
| – | – | 0.01% | 1138 |
|
|
2019
Q3 | $959K | Hold |
12,058
| – | – | 0.01% | 1093 |
|
|
2019
Q2 | $1.05M | Sell |
12,058
-21,965
| -65% | -$1.91M | 0.01% | 1082 |
|
|
2019
Q1 | $3M | Buy |
34,023
+22,682
| +200% | +$1.97M | 0.01% | 1063 |
|
|
2018
Q4 | $1.02M | Hold |
11,341
| – | – | 0.01% | 1009 |
|
|
2018
Q3 | $872K | Sell |
11,341
-1,433
| -11% | -$110K | 0.01% | 1204 |
|
|
2018
Q2 | $873K | Hold |
12,774
| – | – | 0.01% | 1079 |
|
|
2018
Q1 | $846K | Hold |
12,774
| – | – | 0.01% | 1079 |
|
|
2017
Q4 | $781K | Buy |
+12,774
| New | +$866K | 0.01% | 1145 |
|
Other funds holding DORM
KI
MetLife Investment Management's DORM Position: Q2 2026 in Review
MetLife Investment Management increased its Dorman Products (DORM) stake by 2.5% in Q2 2026, buying an estimated $45.1K and bringing the position to 15,757 shares worth $2.15M. The position accounts for 0.01% of the portfolio, ranked #1108.
MetLife Investment Management first reported a position in DORM in Q4 2017 and has held it in 35 quarters since. The position peaked at $3M in Q1 2019. 329 funds tracked by Wall St. Rank hold DORM as of Q2 2026.
- MetLife Investment Management held 15,757 shares of Dorman Products worth $2.15M as of Q2 2026.
- MetLife Investment Management bought 381 Dorman Products shares in Q2 2026, an estimated $45.1K.
- Dorman Products made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1108 holding.
- MetLife Investment Management first reported a position in Dorman Products in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's Dorman Products position peaked at $3M in Q1 2019.
- 329 funds tracked by Wall St. Rank held Dorman Products as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.